We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

73 hedge funds and large institutions have $21.1M invested in T2 Biosystems, Inc in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more call options, than puts

Call options by funds: $470K | Put options by funds: $379K

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

6% less funds holding

Funds holding: 78 → 73 (-5)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

39% less capital invested

Capital invested by funds: $34.6M → $21.1M (-$13.5M)

Holders
73
Holders Change
-5
Holders Change %
-6.41%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
14
Closed
12
Calls
$470K
Puts
$379K
Net Calls
+$91K
Net Calls Change
-$22K

Top Buyers

Rank Fund Capital Flow
1
N
Natixis
France
+$539K
2
GCP
GSA Capital Partners
United Kingdom
+$166K
3
WF
Welch & Forbes
Massachusetts
+$136K
4
Franklin Resources
Franklin Resources
California
+$111K
5
JP Morgan Chase
JP Morgan Chase
New York
+$55.4K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$2.66M
2
Millennium Management
Millennium Management
New York
-$2.06M
3
GS
Gagnon Securities
New York
-$357K
4
BCM
Bridgeway Capital Management
Texas
-$302K
5
Osaic Holdings
Osaic Holdings
Arizona
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
26
HighTower Advisors
Illinois
$65K – – –
Commonwealth Equity Services
27
Commonwealth Equity Services
Massachusetts
$56K – – –
JP Morgan Chase
28
JP Morgan Chase
New York
$50K +$55.4K +11 New
CA
29
Continuum Advisory
Idaho
$47K – – –
ECM
30
ExodusPoint Capital Management
New York
$47K +$10.1K +2 +25%
PFGIA
31
Patriot Financial Group Insurance Agency
Massachusetts
$46K – – –
Charles Schwab
32
Charles Schwab
California
$44K – – –
APP
33
Avantax Planning Partners
Iowa
$37K – – –
Creative Planning
34
Creative Planning
Kansas
$36K – – –
RJA
35
Raymond James & Associates
Florida
$34K – – –
VFA
36
Valeo Financial Advisors
Indiana
$32K +$20.1K +4 +133%
FCMT
37
Founders Capital Management (Texas)
Texas
$27K – – –
Barclays
38
Barclays
United Kingdom
$27K +$20.1K +4 +200%
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$26K +$30.2K +6 New
BAM
40
Brave Asset Management
New Jersey
$24K +$5.03K +1 +25%
AWM
41
AE Wealth Management
Kansas
$23K +$5.03K +1 +25%
TSS
42
Two Sigma Securities
New York
$23K +$25.2K +5 New
Victory Capital Management
43
Victory Capital Management
Texas
$22K – – –
LCS
44
Levin Capital Strategies
New York
$21K -$111K -22 -81%
LPL Financial
45
LPL Financial
California
$21K +$5.03K +1 +25%
IF
46
Ironwood Financial
Arizona
$20K – – –
Wolverine Trading
47
Wolverine Trading
Illinois
$18K -$10.1K -2 -33%
Cambridge Investment Research Advisors
48
Cambridge Investment Research Advisors
Iowa
$18K +$5.03K +1 +33%
US Bancorp
49
US Bancorp
Minnesota
$17K – – –
TCM
50
Traynor Capital Management
Pennsylvania
$17K +$5.03K +1 +33%
1
2
3 4

TTOO Hedge Fund Activity: Q3 2021 in Review

73 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2021, worth a combined $21.1M — down 39% from $34.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of TTOO and 9 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 13 added.

The largest buyer was Natixis, opening a new position worth an estimated $539K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.66M sold.

  • 73 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2021, down from 78 in Q2 2021.
  • Funds reported $21.1M of T2 Biosystems, Inc stock for Q3 2021, down 39% quarter-over-quarter.
  • 9 funds opened new T2 Biosystems, Inc positions in Q3 2021 and 12 closed out, a net change of -3 holders.
  • The largest T2 Biosystems, Inc buyer in Q3 2021 was Natixis, an estimated $539K added.
  • The largest T2 Biosystems, Inc seller in Q3 2021 was Renaissance Technologies, an estimated $2.66M sold.

Based on aggregated 13F filings for Q3 2021.